Mustang Bio, Inc. (MBIO) Social Stream
Mustang Bio Inc (MBIO) Price Targets From Analysts
Use the tables below to see what analysts covering Mustang Bio Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
MBIO's average price target has moved down $1 over the prior 23 months.
Over the past 50 weeks, MBIO's average upside potential has been 298.88%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MBIO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
MBIO's average broker recommendation rating improved by 0 over the prior 16 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MBIO as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Mustang Bio Inc's upside potential (average analyst target price relative to current price) is greater than 491.2% of them.
- To contextualize these metrics, consider that out of all US stocks, Mustang Bio Inc's average analyst price target is greater than 40.56% of them.
- In the context of stocks in the small market cap category, Mustang Bio Inc's variance in analysts' estimates is lower than -266.34% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, Mustang Bio Inc's number of analysts covering the stock is higher than 145.31% of them.
Is MBIO a Buy, Hold or Sell? See the POWR Ratings now!